PROSPECTS FOR THE USE OF LIPIDOMIC ANALYSIS IN THE DIAGNOSIS OF METABOLIC DISORDERS

Lipid metabolism disorders play an important role in the development of a number of diseases associated with obesity. However, not all obese people have the traditional abnormal clinical plasma lipid levels, which is especially common in children and adolescents. Given this controversial relationship it is necessary to clarify the new lipid biomarkers in obesity. From this point of view, of particular interest is lipidomics, which allows identifying the diversity of different types of lipids presented in a cell, tissue, biological fluid or in the entire body using tandem mass spectrometry. The human lipidomic profile reflects lipid metabolism, including the early phase of pathophysiological changes associated with the formation of the obesity phenotype. Studying the connection between the lipidome and metabolic plasticity can provide new insight into the biological mechanisms of the development of obesity and its complications, the relationship between fat and carbohydrate metabolism in the development of insulin resistance, disruption of the functioning of intestinal incretins (cholecystokinin, glucagon-like peptide 1 and 2 etc.). From a public health perspective, a thorough understanding of the pathophysiological changes that lead to obesity at the earliest stage will have far-reaching promise for slowing the enormous global incidence of obesity and type 2 diabetes mellitus. This bibliographical review was conducted using the PubMed, Google Scholar and Cyberleninka databases through 2013-2023 sources.